nodes	percent_of_prediction	percent_of_DWPC	metapath
Lidocaine—EGFR—brain cancer	0.298	0.523	CbGaD
Lidocaine—CYP2C9—brain cancer	0.271	0.477	CbGaD
Lidocaine—CYP2D6—Lomustine—brain cancer	0.0392	0.178	CbGbCtD
Lidocaine—CYP1A2—Carmustine—brain cancer	0.0388	0.176	CbGbCtD
Lidocaine—CYP2D6—Hydroxyurea—brain cancer	0.0297	0.135	CbGbCtD
Lidocaine—CYP3A4—Temozolomide—brain cancer	0.0293	0.133	CbGbCtD
Lidocaine—CYP3A4—Lomustine—brain cancer	0.025	0.113	CbGbCtD
Lidocaine—CYP3A5—Etoposide—brain cancer	0.0155	0.0703	CbGbCtD
Lidocaine—CYP2C8—Etoposide—brain cancer	0.0149	0.0676	CbGbCtD
Lidocaine—CYP1A2—Etoposide—brain cancer	0.0115	0.0523	CbGbCtD
Lidocaine—Neurologic reaction—Lomustine—brain cancer	0.0109	0.0913	CcSEcCtD
Lidocaine—ABCB1—Etoposide—brain cancer	0.0101	0.0457	CbGbCtD
Lidocaine—CYP3A4—Etoposide—brain cancer	0.00603	0.0274	CbGbCtD
Lidocaine—Apprehension—Procarbazine—brain cancer	0.00489	0.0409	CcSEcCtD
Lidocaine—Neurological symptom—Lomustine—brain cancer	0.00489	0.0409	CcSEcCtD
Lidocaine—CNS toxicity—Etoposide—brain cancer	0.00394	0.0329	CcSEcCtD
Lidocaine—Papule—Hydroxyurea—brain cancer	0.00332	0.0278	CcSEcCtD
Lidocaine—Teratogenicity—Carmustine—brain cancer	0.0028	0.0234	CcSEcCtD
Lidocaine—Hoarseness—Procarbazine—brain cancer	0.00213	0.0178	CcSEcCtD
Lidocaine—Slurred speech—Procarbazine—brain cancer	0.0021	0.0175	CcSEcCtD
Lidocaine—Throat sore—Lomustine—brain cancer	0.00205	0.0171	CcSEcCtD
Lidocaine—Oropharyngeal discomfort—Lomustine—brain cancer	0.00203	0.017	CcSEcCtD
Lidocaine—Contusion—Lomustine—brain cancer	0.00169	0.0142	CcSEcCtD
Lidocaine—Oropharyngeal pain—Lomustine—brain cancer	0.00162	0.0136	CcSEcCtD
Lidocaine—Dysarthria—Lomustine—brain cancer	0.00156	0.0131	CcSEcCtD
Lidocaine—Hyperacusis—Temozolomide—brain cancer	0.00152	0.0127	CcSEcCtD
Lidocaine—Meningitis—Carmustine—brain cancer	0.00151	0.0127	CcSEcCtD
Lidocaine—SCN10A—ganglion—brain cancer	0.0015	0.0544	CbGeAlD
Lidocaine—Disorientation—Lomustine—brain cancer	0.0012	0.01	CcSEcCtD
Lidocaine—Procainamide—DNMT1—brain cancer	0.00119	1	CrCbGaD
Lidocaine—SCN2A—hindbrain—brain cancer	0.00118	0.0428	CbGeAlD
Lidocaine—Neurotoxicity—Etoposide—brain cancer	0.00117	0.00979	CcSEcCtD
Lidocaine—Petechiae—Procarbazine—brain cancer	0.00114	0.00954	CcSEcCtD
Lidocaine—Dysphonia—Procarbazine—brain cancer	0.00114	0.00954	CcSEcCtD
Lidocaine—Visual disturbance—Lomustine—brain cancer	0.00113	0.00947	CcSEcCtD
Lidocaine—Osteoarthritis—Lomustine—brain cancer	0.00107	0.00897	CcSEcCtD
Lidocaine—Blister—Hydroxyurea—brain cancer	0.00101	0.00842	CcSEcCtD
Lidocaine—Dysarthria—Procarbazine—brain cancer	0.000991	0.00829	CcSEcCtD
Lidocaine—EGFR—telencephalon—brain cancer	0.000925	0.0335	CbGeAlD
Lidocaine—Neuropathy—Procarbazine—brain cancer	0.00088	0.00737	CcSEcCtD
Lidocaine—Coma—Procarbazine—brain cancer	0.000857	0.00717	CcSEcCtD
Lidocaine—Burning sensation—Carmustine—brain cancer	0.000844	0.00706	CcSEcCtD
Lidocaine—Tenderness—Hydroxyurea—brain cancer	0.000832	0.00696	CcSEcCtD
Lidocaine—Stomatitis—Lomustine—brain cancer	0.000805	0.00674	CcSEcCtD
Lidocaine—Disorientation—Procarbazine—brain cancer	0.000761	0.00637	CcSEcCtD
Lidocaine—Haemoglobin—Lomustine—brain cancer	0.000745	0.00624	CcSEcCtD
Lidocaine—Haemorrhage—Lomustine—brain cancer	0.000742	0.00621	CcSEcCtD
Lidocaine—Hyperaesthesia—Temozolomide—brain cancer	0.000722	0.00604	CcSEcCtD
Lidocaine—Visual impairment—Lomustine—brain cancer	0.000715	0.00598	CcSEcCtD
Lidocaine—Skin exfoliation—Hydroxyurea—brain cancer	0.000693	0.0058	CcSEcCtD
Lidocaine—Petechiae—Temozolomide—brain cancer	0.000689	0.00577	CcSEcCtD
Lidocaine—Diplopia—Procarbazine—brain cancer	0.000681	0.00569	CcSEcCtD
Lidocaine—SCN2A—brainstem—brain cancer	0.000678	0.0245	CbGeAlD
Lidocaine—SCN9A—pituitary gland—brain cancer	0.00062	0.0225	CbGeAlD
Lidocaine—Laryngospasm—Etoposide—brain cancer	0.000608	0.00508	CcSEcCtD
Lidocaine—SCN2A—telencephalon—brain cancer	0.000602	0.0218	CbGeAlD
Lidocaine—Disorientation—Hydroxyurea—brain cancer	0.000589	0.00493	CcSEcCtD
Lidocaine—Dysphagia—Procarbazine—brain cancer	0.000588	0.00492	CcSEcCtD
Lidocaine—SCN10A—telencephalon—brain cancer	0.00058	0.021	CbGeAlD
Lidocaine—Sweating increased—Procarbazine—brain cancer	0.000573	0.00479	CcSEcCtD
Lidocaine—Depressed level of consciousness—Carmustine—brain cancer	0.000567	0.00474	CcSEcCtD
Lidocaine—Urinary incontinence—Carmustine—brain cancer	0.000567	0.00474	CcSEcCtD
Lidocaine—Skin exfoliation—Carmustine—brain cancer	0.00056	0.00469	CcSEcCtD
Lidocaine—SCN4A—pituitary gland—brain cancer	0.000553	0.02	CbGeAlD
Lidocaine—Dermatitis bullous—Hydroxyurea—brain cancer	0.000551	0.00461	CcSEcCtD
Lidocaine—Neuropathy—Carmustine—brain cancer	0.000551	0.00461	CcSEcCtD
Lidocaine—Depressed level of consciousness—Temozolomide—brain cancer	0.000547	0.00458	CcSEcCtD
Lidocaine—Urinary incontinence—Temozolomide—brain cancer	0.000547	0.00458	CcSEcCtD
Lidocaine—Numbness—Etoposide—brain cancer	0.000547	0.00458	CcSEcCtD
Lidocaine—SCN9A—midbrain—brain cancer	0.000547	0.0198	CbGeAlD
Lidocaine—Skin exfoliation—Temozolomide—brain cancer	0.000541	0.00453	CcSEcCtD
Lidocaine—Coma—Carmustine—brain cancer	0.000536	0.00449	CcSEcCtD
Lidocaine—Apnoea—Etoposide—brain cancer	0.000535	0.00448	CcSEcCtD
Lidocaine—SCN9A—spinal cord—brain cancer	0.000534	0.0193	CbGeAlD
Lidocaine—Neuropathy—Temozolomide—brain cancer	0.000532	0.00445	CcSEcCtD
Lidocaine—SCN3A—telencephalon—brain cancer	0.000529	0.0191	CbGeAlD
Lidocaine—Drowsiness—Procarbazine—brain cancer	0.000525	0.00439	CcSEcCtD
Lidocaine—Sensory loss—Etoposide—brain cancer	0.000524	0.00438	CcSEcCtD
Lidocaine—Pain—Carboplatin—brain cancer	0.000515	0.00431	CcSEcCtD
Lidocaine—Neuropathy peripheral—Procarbazine—brain cancer	0.000514	0.0043	CcSEcCtD
Lidocaine—EGFR—cerebellum—brain cancer	0.000514	0.0186	CbGeAlD
Lidocaine—Stomatitis—Procarbazine—brain cancer	0.000511	0.00428	CcSEcCtD
Lidocaine—CYP2C18—endocrine gland—brain cancer	0.000504	0.0183	CbGeAlD
Lidocaine—SCN2A—pituitary gland—brain cancer	0.00049	0.0177	CbGeAlD
Lidocaine—CYP3A7—endocrine gland—brain cancer	0.00048	0.0174	CbGeAlD
Lidocaine—Haemoglobin—Procarbazine—brain cancer	0.000473	0.00396	CcSEcCtD
Lidocaine—SCN2A—medulla oblongata—brain cancer	0.000473	0.0171	CbGeAlD
Lidocaine—SCN10A—pituitary gland—brain cancer	0.000472	0.0171	CbGeAlD
Lidocaine—Haemorrhage—Procarbazine—brain cancer	0.000471	0.00394	CcSEcCtD
Lidocaine—Flushing—Procarbazine—brain cancer	0.000437	0.00366	CcSEcCtD
Lidocaine—Skin exfoliation—Etoposide—brain cancer	0.000433	0.00362	CcSEcCtD
Lidocaine—SCN2A—midbrain—brain cancer	0.000432	0.0156	CbGeAlD
Lidocaine—SCN3A—pituitary gland—brain cancer	0.000431	0.0156	CbGeAlD
Lidocaine—Neuropathy—Etoposide—brain cancer	0.000426	0.00356	CcSEcCtD
Lidocaine—Diplopia—Carmustine—brain cancer	0.000426	0.00356	CcSEcCtD
Lidocaine—SCN4A—head—brain cancer	0.000423	0.0153	CbGeAlD
Lidocaine—Chills—Procarbazine—brain cancer	0.000423	0.00354	CcSEcCtD
Lidocaine—SCN2A—spinal cord—brain cancer	0.000422	0.0153	CbGeAlD
Lidocaine—EGFR—brain—brain cancer	0.000418	0.0151	CbGeAlD
Lidocaine—SCN3A—medulla oblongata—brain cancer	0.000415	0.015	CbGeAlD
Lidocaine—Diplopia—Temozolomide—brain cancer	0.000412	0.00344	CcSEcCtD
Lidocaine—SCN10A—spinal cord—brain cancer	0.000406	0.0147	CbGeAlD
Lidocaine—Drowsiness—Hydroxyurea—brain cancer	0.000406	0.0034	CcSEcCtD
Lidocaine—Tension—Procarbazine—brain cancer	0.000402	0.00337	CcSEcCtD
Lidocaine—Nervousness—Procarbazine—brain cancer	0.000398	0.00333	CcSEcCtD
Lidocaine—Neuropathy peripheral—Hydroxyurea—brain cancer	0.000398	0.00333	CcSEcCtD
Lidocaine—Stomatitis—Hydroxyurea—brain cancer	0.000396	0.00331	CcSEcCtD
Lidocaine—CYP2D6—hindbrain—brain cancer	0.000389	0.0141	CbGeAlD
Lidocaine—SCN4A—central nervous system—brain cancer	0.000386	0.014	CbGeAlD
Lidocaine—Tremor—Procarbazine—brain cancer	0.000384	0.00321	CcSEcCtD
Lidocaine—SCN3A—midbrain—brain cancer	0.00038	0.0137	CbGeAlD
Lidocaine—SCN2A—endocrine gland—brain cancer	0.000379	0.0137	CbGeAlD
Lidocaine—SCN2A—head—brain cancer	0.000375	0.0136	CbGeAlD
Lidocaine—SCN3A—spinal cord—brain cancer	0.00037	0.0134	CbGeAlD
Lidocaine—Dysphagia—Carmustine—brain cancer	0.000368	0.00308	CcSEcCtD
Lidocaine—Haemoglobin—Hydroxyurea—brain cancer	0.000366	0.00306	CcSEcCtD
Lidocaine—SCN10A—endocrine gland—brain cancer	0.000366	0.0132	CbGeAlD
Lidocaine—Haemorrhage—Hydroxyurea—brain cancer	0.000364	0.00305	CcSEcCtD
Lidocaine—SCN10A—head—brain cancer	0.000361	0.0131	CbGeAlD
Lidocaine—Loss of consciousness—Procarbazine—brain cancer	0.00036	0.00301	CcSEcCtD
Lidocaine—Dysphagia—Temozolomide—brain cancer	0.000356	0.00298	CcSEcCtD
Lidocaine—Convulsion—Procarbazine—brain cancer	0.000355	0.00297	CcSEcCtD
Lidocaine—Hypertension—Procarbazine—brain cancer	0.000354	0.00296	CcSEcCtD
Lidocaine—Anxiety—Procarbazine—brain cancer	0.000348	0.00291	CcSEcCtD
Lidocaine—Sweating increased—Temozolomide—brain cancer	0.000346	0.0029	CcSEcCtD
Lidocaine—SCN9A—brain—brain cancer	0.000344	0.0124	CbGeAlD
Lidocaine—SCN2A—central nervous system—brain cancer	0.000342	0.0124	CbGeAlD
Lidocaine—Anaphylactoid reaction—Etoposide—brain cancer	0.00034	0.00285	CcSEcCtD
Lidocaine—Confusional state—Procarbazine—brain cancer	0.000337	0.00282	CcSEcCtD
Lidocaine—Vomiting—Lomustine—brain cancer	0.000335	0.0028	CcSEcCtD
Lidocaine—Oedema—Procarbazine—brain cancer	0.000335	0.0028	CcSEcCtD
Lidocaine—SCN2A—cerebellum—brain cancer	0.000334	0.0121	CbGeAlD
Lidocaine—Angiopathy—Hydroxyurea—brain cancer	0.000331	0.00277	CcSEcCtD
Lidocaine—SCN10A—central nervous system—brain cancer	0.00033	0.0119	CbGeAlD
Lidocaine—SCN3A—head—brain cancer	0.000329	0.0119	CbGeAlD
Lidocaine—Shock—Procarbazine—brain cancer	0.000329	0.00275	CcSEcCtD
Lidocaine—SCN5A—head—brain cancer	0.000328	0.0119	CbGeAlD
Lidocaine—Chills—Hydroxyurea—brain cancer	0.000327	0.00274	CcSEcCtD
Lidocaine—Hyperhidrosis—Procarbazine—brain cancer	0.000323	0.00271	CcSEcCtD
Lidocaine—Neuropathy peripheral—Carmustine—brain cancer	0.000322	0.00269	CcSEcCtD
Lidocaine—Stomatitis—Carmustine—brain cancer	0.00032	0.00268	CcSEcCtD
Lidocaine—Erythema—Hydroxyurea—brain cancer	0.000317	0.00265	CcSEcCtD
Lidocaine—Cardiac arrest—Etoposide—brain cancer	0.000313	0.00262	CcSEcCtD
Lidocaine—Nausea—Lomustine—brain cancer	0.000313	0.00262	CcSEcCtD
Lidocaine—Hypotension—Procarbazine—brain cancer	0.000313	0.00262	CcSEcCtD
Lidocaine—Neuropathy peripheral—Temozolomide—brain cancer	0.000311	0.0026	CcSEcCtD
Lidocaine—Stomatitis—Temozolomide—brain cancer	0.000309	0.00259	CcSEcCtD
Lidocaine—SCN4A—brain—brain cancer	0.000307	0.0111	CbGeAlD
Lidocaine—SCN3A—central nervous system—brain cancer	0.000301	0.0109	CbGeAlD
Lidocaine—Paraesthesia—Procarbazine—brain cancer	0.0003	0.00251	CcSEcCtD
Lidocaine—SCN5A—central nervous system—brain cancer	0.0003	0.0108	CbGeAlD
Lidocaine—Somnolence—Procarbazine—brain cancer	0.000297	0.00249	CcSEcCtD
Lidocaine—Haemoglobin—Carmustine—brain cancer	0.000296	0.00248	CcSEcCtD
Lidocaine—Haemorrhage—Carmustine—brain cancer	0.000295	0.00246	CcSEcCtD
Lidocaine—SCN3A—cerebellum—brain cancer	0.000294	0.0106	CbGeAlD
Lidocaine—CYP2A6—cerebellum—brain cancer	0.000294	0.0106	CbGeAlD
Lidocaine—Hypoaesthesia—Carmustine—brain cancer	0.000293	0.00245	CcSEcCtD
Lidocaine—ABCB1—blood vessel—brain cancer	0.000293	0.0106	CbGeAlD
Lidocaine—Haemoglobin—Temozolomide—brain cancer	0.000286	0.00239	CcSEcCtD
Lidocaine—Pain—Procarbazine—brain cancer	0.000286	0.00239	CcSEcCtD
Lidocaine—Haemorrhage—Temozolomide—brain cancer	0.000285	0.00238	CcSEcCtD
Lidocaine—Dysphagia—Etoposide—brain cancer	0.000285	0.00238	CcSEcCtD
Lidocaine—Visual impairment—Carmustine—brain cancer	0.000284	0.00238	CcSEcCtD
Lidocaine—Hypoaesthesia—Temozolomide—brain cancer	0.000283	0.00237	CcSEcCtD
Lidocaine—Bronchospasm—Etoposide—brain cancer	0.00028	0.00234	CcSEcCtD
Lidocaine—Sweating increased—Etoposide—brain cancer	0.000277	0.00232	CcSEcCtD
Lidocaine—Feeling abnormal—Procarbazine—brain cancer	0.000276	0.00231	CcSEcCtD
Lidocaine—Eye disorder—Carmustine—brain cancer	0.000275	0.0023	CcSEcCtD
Lidocaine—Convulsion—Hydroxyurea—brain cancer	0.000275	0.0023	CcSEcCtD
Lidocaine—Visual impairment—Temozolomide—brain cancer	0.000274	0.0023	CcSEcCtD
Lidocaine—Flushing—Carmustine—brain cancer	0.000273	0.00229	CcSEcCtD
Lidocaine—SCN2A—brain—brain cancer	0.000271	0.00983	CbGeAlD
Lidocaine—Eye disorder—Temozolomide—brain cancer	0.000266	0.00223	CcSEcCtD
Lidocaine—Urticaria—Procarbazine—brain cancer	0.000266	0.00222	CcSEcCtD
Lidocaine—Tinnitus—Temozolomide—brain cancer	0.000265	0.00222	CcSEcCtD
Lidocaine—Cardiac disorder—Temozolomide—brain cancer	0.000264	0.00221	CcSEcCtD
Lidocaine—Flushing—Temozolomide—brain cancer	0.000264	0.00221	CcSEcCtD
Lidocaine—SCN10A—brain—brain cancer	0.000262	0.00948	CbGeAlD
Lidocaine—Oedema—Hydroxyurea—brain cancer	0.000259	0.00217	CcSEcCtD
Lidocaine—Angiopathy—Temozolomide—brain cancer	0.000258	0.00216	CcSEcCtD
Lidocaine—Immune system disorder—Temozolomide—brain cancer	0.000257	0.00215	CcSEcCtD
Lidocaine—Erythema—Carmustine—brain cancer	0.000256	0.00215	CcSEcCtD
Lidocaine—Chills—Temozolomide—brain cancer	0.000255	0.00214	CcSEcCtD
Lidocaine—Nervous system disorder—Hydroxyurea—brain cancer	0.000254	0.00212	CcSEcCtD
Lidocaine—SLC22A5—pituitary gland—brain cancer	0.000249	0.00903	CbGeAlD
Lidocaine—Neuropathy peripheral—Etoposide—brain cancer	0.000249	0.00208	CcSEcCtD
Lidocaine—Back pain—Carmustine—brain cancer	0.000248	0.00208	CcSEcCtD
Lidocaine—Erythema—Temozolomide—brain cancer	0.000248	0.00207	CcSEcCtD
Lidocaine—Stomatitis—Etoposide—brain cancer	0.000247	0.00207	CcSEcCtD
Lidocaine—Hypersensitivity—Procarbazine—brain cancer	0.000246	0.00206	CcSEcCtD
Lidocaine—Dysgeusia—Temozolomide—brain cancer	0.000243	0.00203	CcSEcCtD
Lidocaine—Vision blurred—Carmustine—brain cancer	0.000242	0.00202	CcSEcCtD
Lidocaine—CYP2C8—pituitary gland—brain cancer	0.000241	0.00874	CbGeAlD
Lidocaine—SLC22A5—medulla oblongata—brain cancer	0.000241	0.00871	CbGeAlD
Lidocaine—Tremor—Carmustine—brain cancer	0.00024	0.00201	CcSEcCtD
Lidocaine—Asthenia—Procarbazine—brain cancer	0.00024	0.00201	CcSEcCtD
Lidocaine—Back pain—Temozolomide—brain cancer	0.00024	0.00201	CcSEcCtD
Lidocaine—SCN3A—brain—brain cancer	0.000239	0.00864	CbGeAlD
Lidocaine—CYP2A6—brain—brain cancer	0.000238	0.00863	CbGeAlD
Lidocaine—SCN5A—brain—brain cancer	0.000238	0.00861	CbGeAlD
Lidocaine—Agitation—Carmustine—brain cancer	0.000236	0.00197	CcSEcCtD
Lidocaine—Vision blurred—Temozolomide—brain cancer	0.000234	0.00195	CcSEcCtD
Lidocaine—Tremor—Temozolomide—brain cancer	0.000232	0.00194	CcSEcCtD
Lidocaine—Dyspnoea—Hydroxyurea—brain cancer	0.000231	0.00193	CcSEcCtD
Lidocaine—Somnolence—Hydroxyurea—brain cancer	0.00023	0.00193	CcSEcCtD
Lidocaine—Agitation—Temozolomide—brain cancer	0.000228	0.00191	CcSEcCtD
Lidocaine—Hypoaesthesia—Etoposide—brain cancer	0.000227	0.0019	CcSEcCtD
Lidocaine—Angioedema—Temozolomide—brain cancer	0.000226	0.00189	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000224	0.00187	CcSEcCtD
Lidocaine—CYP2D6—brainstem—brain cancer	0.000223	0.00806	CbGeAlD
Lidocaine—Convulsion—Carmustine—brain cancer	0.000222	0.00186	CcSEcCtD
Lidocaine—CYP2B6—gonad—brain cancer	0.000222	0.00804	CbGeAlD
Lidocaine—Hypertension—Carmustine—brain cancer	0.000221	0.00185	CcSEcCtD
Lidocaine—Pain—Hydroxyurea—brain cancer	0.000221	0.00185	CcSEcCtD
Lidocaine—Dizziness—Procarbazine—brain cancer	0.000221	0.00185	CcSEcCtD
Lidocaine—SLC22A5—midbrain—brain cancer	0.00022	0.00796	CbGeAlD
Lidocaine—Chest pain—Carmustine—brain cancer	0.000218	0.00183	CcSEcCtD
Lidocaine—Anxiety—Carmustine—brain cancer	0.000218	0.00182	CcSEcCtD
Lidocaine—Convulsion—Temozolomide—brain cancer	0.000215	0.0018	CcSEcCtD
Lidocaine—SLC22A5—spinal cord—brain cancer	0.000215	0.00777	CbGeAlD
Lidocaine—Hypertension—Temozolomide—brain cancer	0.000214	0.00179	CcSEcCtD
Lidocaine—Feeling abnormal—Hydroxyurea—brain cancer	0.000213	0.00179	CcSEcCtD
Lidocaine—Eye disorder—Etoposide—brain cancer	0.000213	0.00178	CcSEcCtD
Lidocaine—Vomiting—Procarbazine—brain cancer	0.000213	0.00178	CcSEcCtD
Lidocaine—Cardiac disorder—Etoposide—brain cancer	0.000211	0.00177	CcSEcCtD
Lidocaine—Flushing—Etoposide—brain cancer	0.000211	0.00177	CcSEcCtD
Lidocaine—Confusional state—Carmustine—brain cancer	0.000211	0.00177	CcSEcCtD
Lidocaine—Rash—Procarbazine—brain cancer	0.000211	0.00176	CcSEcCtD
Lidocaine—Dermatitis—Procarbazine—brain cancer	0.000211	0.00176	CcSEcCtD
Lidocaine—Anxiety—Temozolomide—brain cancer	0.00021	0.00176	CcSEcCtD
Lidocaine—Headache—Procarbazine—brain cancer	0.00021	0.00175	CcSEcCtD
Lidocaine—Oedema—Carmustine—brain cancer	0.000209	0.00175	CcSEcCtD
Lidocaine—Angiopathy—Etoposide—brain cancer	0.000207	0.00173	CcSEcCtD
Lidocaine—Immune system disorder—Etoposide—brain cancer	0.000206	0.00172	CcSEcCtD
Lidocaine—Chills—Etoposide—brain cancer	0.000204	0.00171	CcSEcCtD
Lidocaine—Confusional state—Temozolomide—brain cancer	0.000204	0.00171	CcSEcCtD
Lidocaine—Anaphylactic shock—Temozolomide—brain cancer	0.000202	0.00169	CcSEcCtD
Lidocaine—Oedema—Temozolomide—brain cancer	0.000202	0.00169	CcSEcCtD
Lidocaine—Nausea—Procarbazine—brain cancer	0.000199	0.00166	CcSEcCtD
Lidocaine—Nervous system disorder—Temozolomide—brain cancer	0.000198	0.00166	CcSEcCtD
Lidocaine—CYP2D6—telencephalon—brain cancer	0.000198	0.00716	CbGeAlD
Lidocaine—Hypotension—Carmustine—brain cancer	0.000196	0.00164	CcSEcCtD
Lidocaine—Hyperhidrosis—Temozolomide—brain cancer	0.000196	0.00164	CcSEcCtD
Lidocaine—Dysgeusia—Etoposide—brain cancer	0.000194	0.00162	CcSEcCtD
Lidocaine—Back pain—Etoposide—brain cancer	0.000192	0.0016	CcSEcCtD
Lidocaine—Hypersensitivity—Hydroxyurea—brain cancer	0.000191	0.0016	CcSEcCtD
Lidocaine—Paraesthesia—Carmustine—brain cancer	0.000188	0.00157	CcSEcCtD
Lidocaine—CYP2C8—endocrine gland—brain cancer	0.000187	0.00677	CbGeAlD
Lidocaine—Dyspnoea—Carmustine—brain cancer	0.000187	0.00156	CcSEcCtD
Lidocaine—Somnolence—Carmustine—brain cancer	0.000186	0.00156	CcSEcCtD
Lidocaine—Asthenia—Hydroxyurea—brain cancer	0.000186	0.00155	CcSEcCtD
Lidocaine—Paraesthesia—Temozolomide—brain cancer	0.000182	0.00152	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Carmustine—brain cancer	0.000181	0.00151	CcSEcCtD
Lidocaine—Dyspnoea—Temozolomide—brain cancer	0.00018	0.00151	CcSEcCtD
Lidocaine—Somnolence—Temozolomide—brain cancer	0.00018	0.0015	CcSEcCtD
Lidocaine—Pain—Carmustine—brain cancer	0.000179	0.0015	CcSEcCtD
Lidocaine—CYP1A2—endocrine gland—brain cancer	0.000175	0.00634	CbGeAlD
Lidocaine—Gastrointestinal disorder—Temozolomide—brain cancer	0.000175	0.00146	CcSEcCtD
Lidocaine—Loss of consciousness—Etoposide—brain cancer	0.000174	0.00146	CcSEcCtD
Lidocaine—Pain—Temozolomide—brain cancer	0.000173	0.00145	CcSEcCtD
Lidocaine—Feeling abnormal—Carmustine—brain cancer	0.000172	0.00144	CcSEcCtD
Lidocaine—Convulsion—Etoposide—brain cancer	0.000172	0.00144	CcSEcCtD
Lidocaine—Hypertension—Etoposide—brain cancer	0.000171	0.00143	CcSEcCtD
Lidocaine—Dizziness—Hydroxyurea—brain cancer	0.000171	0.00143	CcSEcCtD
Lidocaine—SLC22A5—cerebellum—brain cancer	0.00017	0.00616	CbGeAlD
Lidocaine—CYP3A5—endocrine gland—brain cancer	0.000169	0.00611	CbGeAlD
Lidocaine—Chest pain—Etoposide—brain cancer	0.000169	0.00141	CcSEcCtD
Lidocaine—CYP2B6—endocrine gland—brain cancer	0.000168	0.00607	CbGeAlD
Lidocaine—Feeling abnormal—Temozolomide—brain cancer	0.000167	0.00139	CcSEcCtD
Lidocaine—CYP2C9—endocrine gland—brain cancer	0.000166	0.00602	CbGeAlD
Lidocaine—CYP2B6—head—brain cancer	0.000166	0.006	CbGeAlD
Lidocaine—Vomiting—Hydroxyurea—brain cancer	0.000165	0.00138	CcSEcCtD
Lidocaine—Rash—Hydroxyurea—brain cancer	0.000163	0.00137	CcSEcCtD
Lidocaine—Confusional state—Etoposide—brain cancer	0.000163	0.00137	CcSEcCtD
Lidocaine—Dermatitis—Hydroxyurea—brain cancer	0.000163	0.00136	CcSEcCtD
Lidocaine—Headache—Hydroxyurea—brain cancer	0.000162	0.00136	CcSEcCtD
Lidocaine—Anaphylactic shock—Etoposide—brain cancer	0.000162	0.00135	CcSEcCtD
Lidocaine—Urticaria—Temozolomide—brain cancer	0.000161	0.00134	CcSEcCtD
Lidocaine—Hyperhidrosis—Etoposide—brain cancer	0.000156	0.00131	CcSEcCtD
Lidocaine—Hypersensitivity—Carmustine—brain cancer	0.000154	0.00129	CcSEcCtD
Lidocaine—Nausea—Hydroxyurea—brain cancer	0.000154	0.00129	CcSEcCtD
Lidocaine—Hypotension—Etoposide—brain cancer	0.000151	0.00127	CcSEcCtD
Lidocaine—CYP2B6—central nervous system—brain cancer	0.000151	0.00547	CbGeAlD
Lidocaine—Asthenia—Carmustine—brain cancer	0.00015	0.00126	CcSEcCtD
Lidocaine—Hypersensitivity—Temozolomide—brain cancer	0.000149	0.00125	CcSEcCtD
Lidocaine—Paraesthesia—Etoposide—brain cancer	0.000145	0.00122	CcSEcCtD
Lidocaine—Asthenia—Temozolomide—brain cancer	0.000145	0.00121	CcSEcCtD
Lidocaine—Dyspnoea—Etoposide—brain cancer	0.000144	0.00121	CcSEcCtD
Lidocaine—Somnolence—Etoposide—brain cancer	0.000144	0.0012	CcSEcCtD
Lidocaine—ABCB1—telencephalon—brain cancer	0.000142	0.00515	CbGeAlD
Lidocaine—Gastrointestinal disorder—Etoposide—brain cancer	0.00014	0.00117	CcSEcCtD
Lidocaine—Dizziness—Carmustine—brain cancer	0.000138	0.00116	CcSEcCtD
Lidocaine—Pain—Etoposide—brain cancer	0.000138	0.00116	CcSEcCtD
Lidocaine—SLC22A5—brain—brain cancer	0.000138	0.005	CbGeAlD
Lidocaine—CYP2C8—brain—brain cancer	0.000134	0.00484	CbGeAlD
Lidocaine—Dizziness—Temozolomide—brain cancer	0.000134	0.00112	CcSEcCtD
Lidocaine—Feeling abnormal—Etoposide—brain cancer	0.000133	0.00112	CcSEcCtD
Lidocaine—Vomiting—Carmustine—brain cancer	0.000133	0.00111	CcSEcCtD
Lidocaine—Rash—Carmustine—brain cancer	0.000132	0.0011	CcSEcCtD
Lidocaine—Dermatitis—Carmustine—brain cancer	0.000132	0.0011	CcSEcCtD
Lidocaine—Headache—Carmustine—brain cancer	0.000131	0.0011	CcSEcCtD
Lidocaine—Vomiting—Temozolomide—brain cancer	0.000129	0.00108	CcSEcCtD
Lidocaine—Urticaria—Etoposide—brain cancer	0.000129	0.00108	CcSEcCtD
Lidocaine—Rash—Temozolomide—brain cancer	0.000128	0.00107	CcSEcCtD
Lidocaine—Dermatitis—Temozolomide—brain cancer	0.000127	0.00107	CcSEcCtD
Lidocaine—Headache—Temozolomide—brain cancer	0.000127	0.00106	CcSEcCtD
Lidocaine—CYP3A4—endocrine gland—brain cancer	0.000127	0.00459	CbGeAlD
Lidocaine—CYP2D6—endocrine gland—brain cancer	0.000125	0.00451	CbGeAlD
Lidocaine—Nausea—Carmustine—brain cancer	0.000124	0.00104	CcSEcCtD
Lidocaine—CYP2D6—head—brain cancer	0.000123	0.00446	CbGeAlD
Lidocaine—Nausea—Temozolomide—brain cancer	0.00012	0.00101	CcSEcCtD
Lidocaine—CYP2B6—brain—brain cancer	0.00012	0.00435	CbGeAlD
Lidocaine—Hypersensitivity—Etoposide—brain cancer	0.000119	0.000998	CcSEcCtD
Lidocaine—ABCB1—gonad—brain cancer	0.000119	0.0043	CbGeAlD
Lidocaine—Asthenia—Etoposide—brain cancer	0.000116	0.000972	CcSEcCtD
Lidocaine—ABCB1—pituitary gland—brain cancer	0.000116	0.00419	CbGeAlD
Lidocaine—CYP3A4—central nervous system—brain cancer	0.000114	0.00413	CbGeAlD
Lidocaine—CYP2D6—central nervous system—brain cancer	0.000112	0.00407	CbGeAlD
Lidocaine—ABCB1—medulla oblongata—brain cancer	0.000112	0.00404	CbGeAlD
Lidocaine—CYP2D6—cerebellum—brain cancer	0.00011	0.00398	CbGeAlD
Lidocaine—Dizziness—Etoposide—brain cancer	0.000107	0.000895	CcSEcCtD
Lidocaine—Vomiting—Etoposide—brain cancer	0.000103	0.000861	CcSEcCtD
Lidocaine—ABCB1—midbrain—brain cancer	0.000102	0.0037	CbGeAlD
Lidocaine—Rash—Etoposide—brain cancer	0.000102	0.000854	CcSEcCtD
Lidocaine—Dermatitis—Etoposide—brain cancer	0.000102	0.000853	CcSEcCtD
Lidocaine—Headache—Etoposide—brain cancer	0.000101	0.000848	CcSEcCtD
Lidocaine—ABCB1—spinal cord—brain cancer	9.96e-05	0.00361	CbGeAlD
Lidocaine—Nausea—Etoposide—brain cancer	9.61e-05	0.000804	CcSEcCtD
Lidocaine—ABCB1—endocrine gland—brain cancer	8.97e-05	0.00325	CbGeAlD
Lidocaine—CYP2D6—brain—brain cancer	8.92e-05	0.00323	CbGeAlD
Lidocaine—ABCB1—head—brain cancer	8.86e-05	0.00321	CbGeAlD
Lidocaine—ABCB1—central nervous system—brain cancer	8.08e-05	0.00293	CbGeAlD
Lidocaine—ABCB1—cerebellum—brain cancer	7.9e-05	0.00286	CbGeAlD
Lidocaine—ABCB1—brain—brain cancer	6.42e-05	0.00232	CbGeAlD
Lidocaine—SCN9A—Axon guidance—EGFR—brain cancer	3.61e-05	0.00058	CbGpPWpGaD
Lidocaine—EGFR—Downstream signaling events of B Cell Receptor (BCR)—ERBB2—brain cancer	3.61e-05	0.00058	CbGpPWpGaD
Lidocaine—SCN3A—Developmental Biology—RELA—brain cancer	3.58e-05	0.000575	CbGpPWpGaD
Lidocaine—SCN3A—Developmental Biology—ERBB2—brain cancer	3.56e-05	0.000571	CbGpPWpGaD
Lidocaine—SCN10A—Axon guidance—VEGFA—brain cancer	3.56e-05	0.000571	CbGpPWpGaD
Lidocaine—EGFR—Fc epsilon receptor (FCERI) signaling—RELA—brain cancer	3.47e-05	0.000557	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—BSG—brain cancer	3.47e-05	0.000557	CbGpPWpGaD
Lidocaine—EGFR—Integrated Breast Cancer Pathway—CCND1—brain cancer	3.46e-05	0.000555	CbGpPWpGaD
Lidocaine—SCN3A—Axon guidance—EGFR—brain cancer	3.45e-05	0.000555	CbGpPWpGaD
Lidocaine—EGFR—Signaling by FGFR in disease—ERBB2—brain cancer	3.45e-05	0.000554	CbGpPWpGaD
Lidocaine—EGFR—Fc epsilon receptor (FCERI) signaling—ERBB2—brain cancer	3.45e-05	0.000554	CbGpPWpGaD
Lidocaine—EGFR—DAP12 interactions—ERBB2—brain cancer	3.45e-05	0.000554	CbGpPWpGaD
Lidocaine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	3.44e-05	0.000553	CbGpPWpGaD
Lidocaine—SCN4A—Developmental Biology—RELA—brain cancer	3.44e-05	0.000552	CbGpPWpGaD
Lidocaine—SCN2A—Developmental Biology—RELA—brain cancer	3.44e-05	0.000552	CbGpPWpGaD
Lidocaine—EGFR—Integrated Breast Cancer Pathway—CTNNB1—brain cancer	3.42e-05	0.00055	CbGpPWpGaD
Lidocaine—EGFR—Signaling by NGF—IRS2—brain cancer	3.42e-05	0.00055	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—SKP2—brain cancer	3.42e-05	0.00055	CbGpPWpGaD
Lidocaine—SCN4A—Developmental Biology—ERBB2—brain cancer	3.42e-05	0.000549	CbGpPWpGaD
Lidocaine—SCN2A—Developmental Biology—ERBB2—brain cancer	3.42e-05	0.000549	CbGpPWpGaD
Lidocaine—EGFR—Signaling by EGFR—ERBB2—brain cancer	3.42e-05	0.000549	CbGpPWpGaD
Lidocaine—EGFR—Signaling by EGFR in Cancer—ERBB2—brain cancer	3.39e-05	0.000544	CbGpPWpGaD
Lidocaine—EGFR—Spinal Cord Injury—MYC—brain cancer	3.38e-05	0.000543	CbGpPWpGaD
Lidocaine—EGFR—Signaling by PDGF—ERBB2—brain cancer	3.37e-05	0.000541	CbGpPWpGaD
Lidocaine—SCN2A—Axon guidance—EGFR—brain cancer	3.32e-05	0.000533	CbGpPWpGaD
Lidocaine—SCN4A—Axon guidance—EGFR—brain cancer	3.32e-05	0.000533	CbGpPWpGaD
Lidocaine—SCN10A—Developmental Biology—RELA—brain cancer	3.31e-05	0.000533	CbGpPWpGaD
Lidocaine—SCN10A—Developmental Biology—ERBB2—brain cancer	3.29e-05	0.000529	CbGpPWpGaD
Lidocaine—EGFR—Focal Adhesion—ERBB2—brain cancer	3.26e-05	0.000523	CbGpPWpGaD
Lidocaine—SCN9A—Developmental Biology—CTNNB1—brain cancer	3.25e-05	0.000523	CbGpPWpGaD
Lidocaine—SCN5A—Axon guidance—ERBB2—brain cancer	3.25e-05	0.000521	CbGpPWpGaD
Lidocaine—EGFR—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	3.24e-05	0.000521	CbGpPWpGaD
Lidocaine—EGFR—B Cell Activation—RELA—brain cancer	3.21e-05	0.000516	CbGpPWpGaD
Lidocaine—SCN10A—Axon guidance—EGFR—brain cancer	3.2e-05	0.000514	CbGpPWpGaD
Lidocaine—EGFR—B Cell Activation—ERBB2—brain cancer	3.19e-05	0.000512	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—CDK4—brain cancer	3.17e-05	0.000509	CbGpPWpGaD
Lidocaine—EGFR—Signaling by SCF-KIT—STAT3—brain cancer	3.15e-05	0.000507	CbGpPWpGaD
Lidocaine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	3.14e-05	0.000505	CbGpPWpGaD
Lidocaine—SCN3A—Developmental Biology—CTNNB1—brain cancer	3.11e-05	0.0005	CbGpPWpGaD
Lidocaine—EGFR—NGF signalling via TRKA from the plasma membrane—ERBB2—brain cancer	3.05e-05	0.00049	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	3.02e-05	0.000485	CbGpPWpGaD
Lidocaine—EGFR—Integrated Breast Cancer Pathway—VEGFA—brain cancer	3.01e-05	0.000484	CbGpPWpGaD
Lidocaine—ABCB1—Allograft Rejection—IL2—brain cancer	3.01e-05	0.000483	CbGpPWpGaD
Lidocaine—SCN4A—Developmental Biology—CTNNB1—brain cancer	2.99e-05	0.00048	CbGpPWpGaD
Lidocaine—SCN2A—Developmental Biology—CTNNB1—brain cancer	2.99e-05	0.00048	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—IDH1—brain cancer	2.98e-05	0.000479	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	2.96e-05	0.000476	CbGpPWpGaD
Lidocaine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	2.95e-05	0.000474	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	2.92e-05	0.00047	CbGpPWpGaD
Lidocaine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	2.89e-05	0.000465	CbGpPWpGaD
Lidocaine—SCN10A—Developmental Biology—CTNNB1—brain cancer	2.88e-05	0.000463	CbGpPWpGaD
Lidocaine—EGFR—Focal Adhesion—CCND1—brain cancer	2.88e-05	0.000462	CbGpPWpGaD
Lidocaine—EGFR—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	2.86e-05	0.00046	CbGpPWpGaD
Lidocaine—SCN9A—Developmental Biology—VEGFA—brain cancer	2.86e-05	0.00046	CbGpPWpGaD
Lidocaine—EGFR—Focal Adhesion—CTNNB1—brain cancer	2.85e-05	0.000458	CbGpPWpGaD
Lidocaine—EGFR—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	2.84e-05	0.000456	CbGpPWpGaD
Lidocaine—EGFR—Downstream signal transduction—STAT3—brain cancer	2.84e-05	0.000456	CbGpPWpGaD
Lidocaine—SCN9A—Developmental Biology—STAT3—brain cancer	2.83e-05	0.000455	CbGpPWpGaD
Lidocaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	2.83e-05	0.000454	CbGpPWpGaD
Lidocaine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	2.83e-05	0.000454	CbGpPWpGaD
Lidocaine—EGFR—EGF/EGFR Signaling Pathway—STAT3—brain cancer	2.82e-05	0.000453	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.79e-05	0.000448	CbGpPWpGaD
Lidocaine—EGFR—Spinal Cord Injury—TP53—brain cancer	2.77e-05	0.000446	CbGpPWpGaD
Lidocaine—EGFR—Integrated Breast Cancer Pathway—MYC—brain cancer	2.77e-05	0.000446	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—PTCH2—brain cancer	2.75e-05	0.000441	CbGpPWpGaD
Lidocaine—SCN3A—Developmental Biology—VEGFA—brain cancer	2.74e-05	0.00044	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	2.72e-05	0.000437	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—VAV1—brain cancer	2.72e-05	0.000436	CbGpPWpGaD
Lidocaine—SCN3A—Developmental Biology—STAT3—brain cancer	2.71e-05	0.000436	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—CYP2C9—brain cancer	2.71e-05	0.000435	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—HES5—brain cancer	2.66e-05	0.000428	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	2.65e-05	0.000426	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—HES1—brain cancer	2.64e-05	0.000425	CbGpPWpGaD
Lidocaine—SCN4A—Developmental Biology—VEGFA—brain cancer	2.63e-05	0.000423	CbGpPWpGaD
Lidocaine—SCN2A—Developmental Biology—VEGFA—brain cancer	2.63e-05	0.000423	CbGpPWpGaD
Lidocaine—EGFR—Signaling by FGFR in disease—STAT3—brain cancer	2.63e-05	0.000422	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—VAV1—brain cancer	2.61e-05	0.000419	CbGpPWpGaD
Lidocaine—SCN2A—Developmental Biology—STAT3—brain cancer	2.61e-05	0.000419	CbGpPWpGaD
Lidocaine—SCN4A—Developmental Biology—STAT3—brain cancer	2.61e-05	0.000419	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	2.59e-05	0.000416	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—STRADA—brain cancer	2.58e-05	0.000415	CbGpPWpGaD
Lidocaine—SCN9A—Developmental Biology—EGFR—brain cancer	2.58e-05	0.000414	CbGpPWpGaD
Lidocaine—EGFR—Signaling by PDGF—STAT3—brain cancer	2.57e-05	0.000413	CbGpPWpGaD
Lidocaine—EGFR—Disease—IDH1—brain cancer	2.56e-05	0.000411	CbGpPWpGaD
Lidocaine—ABCB1—Allograft Rejection—VEGFA—brain cancer	2.55e-05	0.00041	CbGpPWpGaD
Lidocaine—EGFR—MAPK Signaling Pathway—MYC—brain cancer	2.55e-05	0.000409	CbGpPWpGaD
Lidocaine—SCN10A—Developmental Biology—VEGFA—brain cancer	2.54e-05	0.000408	CbGpPWpGaD
Lidocaine—SCN10A—Developmental Biology—STAT3—brain cancer	2.51e-05	0.000404	CbGpPWpGaD
Lidocaine—EGFR—Focal Adhesion—VEGFA—brain cancer	2.51e-05	0.000403	CbGpPWpGaD
Lidocaine—SCN5A—Axon guidance—VEGFA—brain cancer	2.5e-05	0.000402	CbGpPWpGaD
Lidocaine—EGFR—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	2.5e-05	0.000401	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—CYP2C9—brain cancer	2.48e-05	0.000399	CbGpPWpGaD
Lidocaine—SCN3A—Developmental Biology—EGFR—brain cancer	2.46e-05	0.000396	CbGpPWpGaD
Lidocaine—EGFR—Disease—HEY1—brain cancer	2.42e-05	0.000389	CbGpPWpGaD
Lidocaine—EGFR—Direct p53 effectors—TP53—brain cancer	2.42e-05	0.000389	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—SHH—brain cancer	2.4e-05	0.000385	CbGpPWpGaD
Lidocaine—EGFR—Disease—DLL1—brain cancer	2.38e-05	0.000382	CbGpPWpGaD
Lidocaine—SCN4A—Developmental Biology—EGFR—brain cancer	2.37e-05	0.00038	CbGpPWpGaD
Lidocaine—SCN2A—Developmental Biology—EGFR—brain cancer	2.37e-05	0.00038	CbGpPWpGaD
Lidocaine—EGFR—Signaling by NGF—RELA—brain cancer	2.36e-05	0.00038	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—ENO2—brain cancer	2.36e-05	0.000379	CbGpPWpGaD
Lidocaine—EGFR—Signaling by NGF—ERBB2—brain cancer	2.35e-05	0.000377	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—RELA—brain cancer	2.33e-05	0.000374	CbGpPWpGaD
Lidocaine—EGFR—NGF signalling via TRKA from the plasma membrane—STAT3—brain cancer	2.33e-05	0.000374	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—ERBB2—brain cancer	2.32e-05	0.000372	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—TRPC6—brain cancer	2.31e-05	0.000371	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—BSG—brain cancer	2.3e-05	0.00037	CbGpPWpGaD
Lidocaine—EGFR—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	2.3e-05	0.000369	CbGpPWpGaD
Lidocaine—SCN10A—Developmental Biology—EGFR—brain cancer	2.28e-05	0.000367	CbGpPWpGaD
Lidocaine—EGFR—Integrated Breast Cancer Pathway—TP53—brain cancer	2.28e-05	0.000366	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—PTCH1—brain cancer	2.27e-05	0.000365	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—SMO—brain cancer	2.27e-05	0.000365	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.27e-05	0.000364	CbGpPWpGaD
Lidocaine—SCN5A—Axon guidance—EGFR—brain cancer	2.25e-05	0.000361	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	2.24e-05	0.00036	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—PDGFRA—brain cancer	2.22e-05	0.000357	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—ABR—brain cancer	2.16e-05	0.000346	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—PDGFRA—brain cancer	2.14e-05	0.000343	CbGpPWpGaD
Lidocaine—EGFR—Axon guidance—ERBB2—brain cancer	2.12e-05	0.000341	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—BSG—brain cancer	2.11e-05	0.000339	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	2.11e-05	0.000339	CbGpPWpGaD
Lidocaine—EGFR—MAPK Signaling Pathway—TP53—brain cancer	2.09e-05	0.000336	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—GLI2—brain cancer	2.08e-05	0.000335	CbGpPWpGaD
Lidocaine—EGFR—Immune System—SKP2—brain cancer	2.08e-05	0.000333	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—CDK4—brain cancer	2.07e-05	0.000333	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—CTNNB1—brain cancer	2.03e-05	0.000325	CbGpPWpGaD
Lidocaine—EGFR—Disease—SHH—brain cancer	2.02e-05	0.000325	CbGpPWpGaD
Lidocaine—EGFR—Disease—ENO2—brain cancer	2.02e-05	0.000325	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—CYP2C9—brain cancer	2e-05	0.000322	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—IDH1—brain cancer	1.98e-05	0.000318	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—CYP2C9—brain cancer	1.96e-05	0.000315	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—GLI1—brain cancer	1.96e-05	0.000315	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—IRS2—brain cancer	1.95e-05	0.000314	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.94e-05	0.000311	CbGpPWpGaD
Lidocaine—EGFR—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	1.89e-05	0.000303	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—IRS2—brain cancer	1.88e-05	0.000301	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—SUFU—brain cancer	1.86e-05	0.000298	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—IDH1—brain cancer	1.82e-05	0.000292	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—GFAP—brain cancer	1.79e-05	0.000288	CbGpPWpGaD
Lidocaine—EGFR—Signaling by NGF—STAT3—brain cancer	1.79e-05	0.000288	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—VEGFA—brain cancer	1.78e-05	0.000287	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—STAT3—brain cancer	1.77e-05	0.000284	CbGpPWpGaD
Lidocaine—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	1.76e-05	0.000283	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—VAV1—brain cancer	1.73e-05	0.000278	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—BSG—brain cancer	1.7e-05	0.000274	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—HEY1—brain cancer	1.7e-05	0.000273	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—CYP2C9—brain cancer	1.7e-05	0.000273	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—BSG—brain cancer	1.67e-05	0.000268	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—DLL1—brain cancer	1.66e-05	0.000267	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	1.64e-05	0.000263	CbGpPWpGaD
Lidocaine—EGFR—Axon guidance—VEGFA—brain cancer	1.64e-05	0.000263	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—EGFR—brain cancer	1.61e-05	0.000258	CbGpPWpGaD
Lidocaine—EGFR—Immune System—VAV1—brain cancer	1.58e-05	0.000254	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—ENO2—brain cancer	1.57e-05	0.000252	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—RELA—brain cancer	1.53e-05	0.000245	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—ERBB2—brain cancer	1.52e-05	0.000244	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—CYP2C9—brain cancer	1.48e-05	0.000238	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—IDH1—brain cancer	1.47e-05	0.000235	CbGpPWpGaD
Lidocaine—EGFR—Disease—VAV1—brain cancer	1.46e-05	0.000235	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	1.45e-05	0.000232	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—BSG—brain cancer	1.44e-05	0.000232	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—ENO2—brain cancer	1.44e-05	0.000231	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—IDH1—brain cancer	1.43e-05	0.00023	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	1.43e-05	0.00023	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—SHH—brain cancer	1.42e-05	0.000227	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—CYP2C9—brain cancer	1.39e-05	0.000224	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—TRPC6—brain cancer	1.37e-05	0.000219	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—RELA—brain cancer	1.35e-05	0.000216	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—SMO—brain cancer	1.34e-05	0.000216	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—PTCH1—brain cancer	1.34e-05	0.000216	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—ERBB2—brain cancer	1.34e-05	0.000215	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—CTNNB1—brain cancer	1.33e-05	0.000213	CbGpPWpGaD
Lidocaine—EGFR—Immune System—PDGFRA—brain cancer	1.3e-05	0.000208	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—RELA—brain cancer	1.29e-05	0.000208	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—ERBB2—brain cancer	1.29e-05	0.000207	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	1.26e-05	0.000203	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—BSG—brain cancer	1.26e-05	0.000202	CbGpPWpGaD
Lidocaine—EGFR—Disease—HES1—brain cancer	1.26e-05	0.000202	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—IDH1—brain cancer	1.24e-05	0.000199	CbGpPWpGaD
Lidocaine—EGFR—Disease—PDGFRA—brain cancer	1.2e-05	0.000192	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—BSG—brain cancer	1.18e-05	0.00019	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—CYP2C9—brain cancer	1.18e-05	0.00019	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—BSG—brain cancer	1.17e-05	0.000189	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—CTNNB1—brain cancer	1.17e-05	0.000188	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—VEGFA—brain cancer	1.17e-05	0.000188	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	1.16e-05	0.000186	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—ENO2—brain cancer	1.16e-05	0.000186	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—STAT3—brain cancer	1.16e-05	0.000186	CbGpPWpGaD
Lidocaine—EGFR—Immune System—IRS2—brain cancer	1.14e-05	0.000183	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	1.13e-05	0.000182	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—ENO2—brain cancer	1.13e-05	0.000182	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—PIK3CG—brain cancer	1.1e-05	0.000177	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—IDH1—brain cancer	1.08e-05	0.000174	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—PIK3CG—brain cancer	1.08e-05	0.000174	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—NOTCH2—brain cancer	1.07e-05	0.000172	CbGpPWpGaD
Lidocaine—EGFR—Disease—IRS2—brain cancer	1.05e-05	0.000169	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—VAV1—brain cancer	1.02e-05	0.000164	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—IDH1—brain cancer	1.02e-05	0.000164	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.01e-05	0.000162	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—IDH1—brain cancer	1.01e-05	0.000162	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—BSG—brain cancer	1e-05	0.000161	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—ENO2—brain cancer	9.81e-06	0.000158	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	9.53e-06	0.000153	CbGpPWpGaD
Lidocaine—EGFR—Disease—APC—brain cancer	9.27e-06	0.000149	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—CYP2C9—brain cancer	9.11e-06	0.000146	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—HES1—brain cancer	8.8e-06	0.000141	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—IDH1—brain cancer	8.63e-06	0.000139	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—ENO2—brain cancer	8.55e-06	0.000137	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—PDGFRA—brain cancer	8.38e-06	0.000135	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	8.22e-06	0.000132	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—SPP1—brain cancer	8.13e-06	0.000131	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—ENO2—brain cancer	8.05e-06	0.000129	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—ENO2—brain cancer	7.98e-06	0.000128	CbGpPWpGaD
Lidocaine—EGFR—Immune System—RELA—brain cancer	7.85e-06	0.000126	CbGpPWpGaD
Lidocaine—EGFR—Immune System—ERBB2—brain cancer	7.8e-06	0.000125	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—BSG—brain cancer	7.74e-06	0.000124	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—IL2—brain cancer	7.74e-06	0.000124	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—IRS2—brain cancer	7.35e-06	0.000118	CbGpPWpGaD
Lidocaine—EGFR—Disease—ERBB2—brain cancer	7.2e-06	0.000116	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—PIK3CG—brain cancer	7.19e-06	0.000115	CbGpPWpGaD
Lidocaine—EGFR—Immune System—IL2—brain cancer	7.07e-06	0.000114	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	7.03e-06	0.000113	CbGpPWpGaD
Lidocaine—EGFR—Immune System—CTNNB1—brain cancer	6.82e-06	0.00011	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—ENO2—brain cancer	6.82e-06	0.00011	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—IDH1—brain cancer	6.66e-06	0.000107	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—PIK3CG—brain cancer	6.59e-06	0.000106	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—APC—brain cancer	6.49e-06	0.000104	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—PIK3CG—brain cancer	6.49e-06	0.000104	CbGpPWpGaD
Lidocaine—EGFR—Disease—CTNNB1—brain cancer	6.3e-06	0.000101	CbGpPWpGaD
Lidocaine—EGFR—Immune System—STAT3—brain cancer	5.95e-06	9.56e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—STAT3—brain cancer	5.49e-06	8.82e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—PIK3CG—brain cancer	5.31e-06	8.54e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—ENO2—brain cancer	5.26e-06	8.46e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—PIK3CG—brain cancer	5.19e-06	8.35e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—MYC—brain cancer	5.1e-06	8.2e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—RELA—brain cancer	5.07e-06	8.15e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—ERBB2—brain cancer	5.04e-06	8.1e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—IL2—brain cancer	4.57e-06	7.34e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—PIK3CG—brain cancer	4.5e-06	7.23e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CCND1—brain cancer	4.45e-06	7.16e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CTNNB1—brain cancer	4.41e-06	7.09e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—PIK3CG—brain cancer	3.92e-06	6.3e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—VEGFA—brain cancer	3.88e-06	6.24e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—STAT3—brain cancer	3.85e-06	6.18e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—PIK3CG—brain cancer	3.69e-06	5.93e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—PIK3CG—brain cancer	3.66e-06	5.88e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—MYC—brain cancer	3.57e-06	5.74e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PIK3CG—brain cancer	3.13e-06	5.03e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—TP53—brain cancer	2.93e-06	4.71e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PIK3CG—brain cancer	2.42e-06	3.88e-05	CbGpPWpGaD
